TCOTS
CRL icon

Trust Company of the South’s Charles River Laboratories CRL Stock Holding History

Trust Company of the South’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,042
Closed -$205K – 123
2024
Q3 		$205K Buy
+1,042
New +$217K 0.04% 127

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return
Koshinski Asset Management
Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
IC
Impactive Capital New York City, New York $1.38B AUM 1.92% 1-Year Est. Return
MG
Meritage Group San Francisco, California $2.65B AUM 6.3% 1-Year Est. Return

Trust Company of the South's CRL Position: Q4 2024 in Review

Trust Company of the South sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 1,042 shares — an estimated $205K sold.

Trust Company of the South first reported a position in CRL in Q3 2024 and held it in 1 quarter. The position peaked at $205K in Q3 2024. 636 funds tracked by Wall St. Rank hold CRL as of Q4 2024.

  • Trust Company of the South reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
  • Trust Company of the South sold 1,042 Charles River Laboratories shares in Q4 2024, an estimated $205K.
  • Trust Company of the South first reported a position in Charles River Laboratories in Q3 2024 and held it in 1 quarter.
  • Trust Company of the South's Charles River Laboratories position peaked at $205K in Q3 2024.
  • 636 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.

Based on Trust Company of the South's 13F filing for Q4 2024, filed 2 Jan 2025.